Cargando…
The transcriptomic responses of blunt snout bream (Megalobrama amblycephala) to acute hypoxia stress alone, and in combination with bortezomib
BACKGROUND: Blunt snout bream (Megalobrama amblycephala) is sensitive to hypoxia. A new blunt snout bream strain, “Pujiang No.2”, was developed to overcome this shortcoming. As a proteasome inhibitor, bortezomib (PS-341) has been shown to affect the adaptation of cells to a hypoxic environment. In t...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876555/ https://www.ncbi.nlm.nih.gov/pubmed/35216548 http://dx.doi.org/10.1186/s12864-022-08399-7 |
_version_ | 1784658202279804928 |
---|---|
author | Zhao, Shan-Shan Su, Xiao-Lei Pan, Rong-Jia Lu, Li-Qun Zheng, Guo-Dong Zou, Shu-Ming |
author_facet | Zhao, Shan-Shan Su, Xiao-Lei Pan, Rong-Jia Lu, Li-Qun Zheng, Guo-Dong Zou, Shu-Ming |
author_sort | Zhao, Shan-Shan |
collection | PubMed |
description | BACKGROUND: Blunt snout bream (Megalobrama amblycephala) is sensitive to hypoxia. A new blunt snout bream strain, “Pujiang No.2”, was developed to overcome this shortcoming. As a proteasome inhibitor, bortezomib (PS-341) has been shown to affect the adaptation of cells to a hypoxic environment. In the present study, bortezomib was used to explore the hypoxia adaptation mechanism of “Pujiang No.2”. We examined how acute hypoxia alone (hypoxia-treated, HN: 1.0 mg·L(− 1)), and in combination with bortezomib (hypoxia-bortezomib-treated, HB: Use 1 mg bortezomib for 1 kg fish), impacted the hepatic ultrastructure and transcriptome expression compared to control fish (normoxia-treated, NN). RESULTS: Hypoxia tolerance was significantly decreased in the bortezomib-treated group (LOE(crit), loss of equilibrium, 1.11 mg·L(− 1) and 1.32 mg·L(− 1)) compared to the control group (LOE(crit), 0.73 mg·L(− 1) and 0.85 mg·L(− 1)). The HB group had more severe liver injury than the HN group. Specifically, the activities of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in the HB group (52.16 U/gprot, 32 U/gprot) were significantly (p < 0.01) higher than those in the HN group (32.85 U/gprot, 21. 68 U/gprot). In addition, more severe liver damage such as vacuoles, nuclear atrophy, and nuclear lysis were observed in the HB group. RNA-seq was performed on livers from the HN, HB and NN groups. KEGG pathway analysis disclosed that many DEGs (differently expressed genes) were enriched in the HIF-1, FOXO, MAPK, PI3K-Akt and AMPK signaling pathway and their downstream. CONCLUSION: We explored the adaptation mechanism of “Pujiang No.2” to hypoxia stress by using bortezomib, and combined with transcriptome analysis, accurately captured the genes related to hypoxia tolerance advantage. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12864-022-08399-7. |
format | Online Article Text |
id | pubmed-8876555 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-88765552022-02-28 The transcriptomic responses of blunt snout bream (Megalobrama amblycephala) to acute hypoxia stress alone, and in combination with bortezomib Zhao, Shan-Shan Su, Xiao-Lei Pan, Rong-Jia Lu, Li-Qun Zheng, Guo-Dong Zou, Shu-Ming BMC Genomics Research BACKGROUND: Blunt snout bream (Megalobrama amblycephala) is sensitive to hypoxia. A new blunt snout bream strain, “Pujiang No.2”, was developed to overcome this shortcoming. As a proteasome inhibitor, bortezomib (PS-341) has been shown to affect the adaptation of cells to a hypoxic environment. In the present study, bortezomib was used to explore the hypoxia adaptation mechanism of “Pujiang No.2”. We examined how acute hypoxia alone (hypoxia-treated, HN: 1.0 mg·L(− 1)), and in combination with bortezomib (hypoxia-bortezomib-treated, HB: Use 1 mg bortezomib for 1 kg fish), impacted the hepatic ultrastructure and transcriptome expression compared to control fish (normoxia-treated, NN). RESULTS: Hypoxia tolerance was significantly decreased in the bortezomib-treated group (LOE(crit), loss of equilibrium, 1.11 mg·L(− 1) and 1.32 mg·L(− 1)) compared to the control group (LOE(crit), 0.73 mg·L(− 1) and 0.85 mg·L(− 1)). The HB group had more severe liver injury than the HN group. Specifically, the activities of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in the HB group (52.16 U/gprot, 32 U/gprot) were significantly (p < 0.01) higher than those in the HN group (32.85 U/gprot, 21. 68 U/gprot). In addition, more severe liver damage such as vacuoles, nuclear atrophy, and nuclear lysis were observed in the HB group. RNA-seq was performed on livers from the HN, HB and NN groups. KEGG pathway analysis disclosed that many DEGs (differently expressed genes) were enriched in the HIF-1, FOXO, MAPK, PI3K-Akt and AMPK signaling pathway and their downstream. CONCLUSION: We explored the adaptation mechanism of “Pujiang No.2” to hypoxia stress by using bortezomib, and combined with transcriptome analysis, accurately captured the genes related to hypoxia tolerance advantage. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12864-022-08399-7. BioMed Central 2022-02-25 /pmc/articles/PMC8876555/ /pubmed/35216548 http://dx.doi.org/10.1186/s12864-022-08399-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Zhao, Shan-Shan Su, Xiao-Lei Pan, Rong-Jia Lu, Li-Qun Zheng, Guo-Dong Zou, Shu-Ming The transcriptomic responses of blunt snout bream (Megalobrama amblycephala) to acute hypoxia stress alone, and in combination with bortezomib |
title | The transcriptomic responses of blunt snout bream (Megalobrama amblycephala) to acute hypoxia stress alone, and in combination with bortezomib |
title_full | The transcriptomic responses of blunt snout bream (Megalobrama amblycephala) to acute hypoxia stress alone, and in combination with bortezomib |
title_fullStr | The transcriptomic responses of blunt snout bream (Megalobrama amblycephala) to acute hypoxia stress alone, and in combination with bortezomib |
title_full_unstemmed | The transcriptomic responses of blunt snout bream (Megalobrama amblycephala) to acute hypoxia stress alone, and in combination with bortezomib |
title_short | The transcriptomic responses of blunt snout bream (Megalobrama amblycephala) to acute hypoxia stress alone, and in combination with bortezomib |
title_sort | transcriptomic responses of blunt snout bream (megalobrama amblycephala) to acute hypoxia stress alone, and in combination with bortezomib |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876555/ https://www.ncbi.nlm.nih.gov/pubmed/35216548 http://dx.doi.org/10.1186/s12864-022-08399-7 |
work_keys_str_mv | AT zhaoshanshan thetranscriptomicresponsesofbluntsnoutbreammegalobramaamblycephalatoacutehypoxiastressaloneandincombinationwithbortezomib AT suxiaolei thetranscriptomicresponsesofbluntsnoutbreammegalobramaamblycephalatoacutehypoxiastressaloneandincombinationwithbortezomib AT panrongjia thetranscriptomicresponsesofbluntsnoutbreammegalobramaamblycephalatoacutehypoxiastressaloneandincombinationwithbortezomib AT luliqun thetranscriptomicresponsesofbluntsnoutbreammegalobramaamblycephalatoacutehypoxiastressaloneandincombinationwithbortezomib AT zhengguodong thetranscriptomicresponsesofbluntsnoutbreammegalobramaamblycephalatoacutehypoxiastressaloneandincombinationwithbortezomib AT zoushuming thetranscriptomicresponsesofbluntsnoutbreammegalobramaamblycephalatoacutehypoxiastressaloneandincombinationwithbortezomib AT zhaoshanshan transcriptomicresponsesofbluntsnoutbreammegalobramaamblycephalatoacutehypoxiastressaloneandincombinationwithbortezomib AT suxiaolei transcriptomicresponsesofbluntsnoutbreammegalobramaamblycephalatoacutehypoxiastressaloneandincombinationwithbortezomib AT panrongjia transcriptomicresponsesofbluntsnoutbreammegalobramaamblycephalatoacutehypoxiastressaloneandincombinationwithbortezomib AT luliqun transcriptomicresponsesofbluntsnoutbreammegalobramaamblycephalatoacutehypoxiastressaloneandincombinationwithbortezomib AT zhengguodong transcriptomicresponsesofbluntsnoutbreammegalobramaamblycephalatoacutehypoxiastressaloneandincombinationwithbortezomib AT zoushuming transcriptomicresponsesofbluntsnoutbreammegalobramaamblycephalatoacutehypoxiastressaloneandincombinationwithbortezomib |